Farrell Michael J.
SEC CIK 1485164 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RMD | ResMed| | COB, CEO, Dir | 471.2K | — | $85.18M | 127 | 2021-08-19 | 2026-09-08 |
Most active insiders at RMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farrell Michael J. | COB, CEO, Dir | — | $15.74M |
| 2 | FARRELL PETER C | Dir | — | $5.01M |
| 3 | Sandercock Brett | CFO | — | $2.79M |
| 4 | De Witte Jan | Dir | — | $645.9K |
| 5 | Rider Michael J | Gbl GC | — | $64.7K |
| 6 | Mowad-Nassar Nicole | Dir | — | — |
| 7 | Hernandez John | Dir | — | — |
| 8 | Tan Desney | Dir | — | — |
| 9 | DelOrefice Christopher | Dir | — | — |
| 10 | Leong Justin | Chief Product Off | — | — |
Transactions 127
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-19 | 2022-09-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 428.2K | +1% | +$327.8K |
| D | 2022-09-19 | 2022-09-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $228.96 | -5,675 | 422.6K | -1% | -$1.30M |
| 2022-08-22 | 2022-08-18 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +17.3K | 422.6K | +4% | $0 | |
| D | 2022-08-17 | 2022-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $238.09 | -5,675 | 405.3K | -1% | -$1.35M |
| D | 2022-08-17 | 2022-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-07-18 | 2022-07-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $224.94 | -5,675 | 405.3K | -1% | -$1.28M |
| D | 2022-07-18 | 2022-07-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-06-16 | 2022-06-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-06-16 | 2022-06-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $202.54 | -5,675 | 405.3K | -1% | -$1.15M |
| D | 2022-05-17 | 2022-05-16 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-05-17 | 2022-05-16 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $196.61 | -5,675 | 405.3K | -1% | -$1.12M |
| D | 2022-04-19 | 2022-04-18 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $232.41 | -5,675 | 405.2K | -1% | -$1.32M |
| D | 2022-04-19 | 2022-04-18 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-03-16 | 2022-03-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-03-16 | 2022-03-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $242.37 | -5,675 | 405.2K | -1% | -$1.38M |
| D | 2022-02-16 | 2022-02-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-02-16 | 2022-02-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $234.06 | -5,675 | 405.2K | -1% | -$1.33M |
| D | 2022-01-20 | 2022-01-18 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2022-01-20 | 2022-01-18 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $241.94 | -5,675 | 405.2K | -1% | -$1.37M |
| D | 2021-12-17 | 2021-12-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 410.9K | +1% | +$327.8K |
| D | 2021-12-17 | 2021-12-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $255.53 | -5,675 | 405.2K | -1% | -$1.45M |
| MI | 2021-12-01 | 2021-11-30 | RMD | ResMed| | Farrell Michael J. | CEO | G - Gift | $0.00 | 0 | 3,880 | New | $0 |
| M | 2021-11-18 | 2021-11-16+ | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $239.77 | +75.7K | 487.2K | +18% | +$18.16M |
| 2021-11-18 | 2021-11-19 | RMD | ResMed| | Farrell Michael J. | CEO | G - Gift | $0.00 | -44.2K | 405.2K | -10% | $0 | |
| 2021-11-18 | 2021-11-17 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $254.81 | -42.2K | 445.0K | -9% | -$10.76M | |
| 2021-11-15 | 2021-11-11 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $259.47 | -8,748 | 416.0K | -2% | -$2.27M | |
| 2021-08-20 | 2021-08-19 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +18.4K | 424.6K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations